archive
REX·DAILY
Saturday July 18 Anno 2026 · Ibaraki, Osaka
I Daily Wisdom
Robert Greene The Daily Laws July 18 · Prove Yourself

Making your deed as dashing and chivalrous as possible will elevate the seduction to a new level, stir up deep emotions, and conceal any ulterior motives you may have. The sacrifices you are making must be visible; talking about them, or explaining what they have cost you, will seem like bragging. Lose sleep, fall ill, lose valuable time, put your career on the line, spend more money than you can afford. You can exaggerate all this for effect, but don’t get caught boasting about it or feeling sorry for yourself: cause yourself pain and let them see it. Since almost everyone else in the world seems to have an angle, your noble and selfless deed will be irresistible.

Daily Law: Choose a dramatic, difficult action that reveals the painful time and effort involved.

The Art of Seduction

: Prove Yourself

Steven Pressfield The Daily Pressfield Day 199

THE MORE THE HERO SUFFERS, THE BETTER We learn from stories. We learn about life. That’s why the hero must suffer. We the readers, the moviegoers, don’t want a shallow vicarious experience. We want our detective, our prize fighter, our desperate housewife to push his or her drama to the limit. The stakes in every great story are life and death, or worse. Remember what Edward G. Robinson as Barton Keyes declared (thank you, Billy Wilder) in Double Ind emnity: BARTON KEYES They’re stuck with each other and they gotta ride all the way to the end of the line and it’s a one-way trip and the last stop is the cemetery. Unpublished Black Irish JAB, “Make Your Hero Suffer, Pa rt Two” The hero is us. We’re living his or her life, and we want to live it to the last breath and the final drop of blood. Extreme happiness plays great for a few moments. But extreme suffering, as long as its forms keep changing, is always interesting.

Leo Tolstoy A Calendar of Wisdom July 18

People believe in eternal life because they believe that life’s beginning is spiritual, and therefore eternal.

In our soul is the sign of eternity.

—WILLIAM ELLERY CHANNING

Our biggest desire is to live forever.

But when we are freed from this body, we will not wish to come back.

Is there such a child who, once born, would like to return to the womb of his mother?

Is there a man who, freed from prison, would like to return to it?

In the same way, a person should not be afraid about the future liberation from his body, if he is not connected too closely with this material life.

—TABLES OF THE BABIDS, a MUSLIM sect from PERSIA

A person is not afraid to die only after he understands that he was never born, that he always existed, exists at present, and will always exist.

A person will believe in his eternity when he understands that his life is not a wave, a period of time, but the eternal movement which is manifested in this life only as a wave.

Those who believe that their life has not begun with their birth and will not end with death find it much easier to live a good life than those who do not understand or believe this.

II The Day Ahead
  • Today · 09:00 毎月の黙想会 2026年間予定
  • Mon · all day Sea Day Holidays in Japan
III Signals & Dispatches

AI / ML

  • @fabrice_mayrandsource ↗ Cheaper Inference is pitching a drop in OpenAI compatible API that routes major models at roughly 30 percent lower cost, useful if reliability checks hold.
  • @LumRamabajasource ↗ A live worry in AI policy is whether Washington starts treating model access as a national control point rather than a market service.

Drug Discovery

  • @ZainKhalpeysource ↗ Biomni is being framed as agentic AI for biomedical research, combining reasoning with tools and databases for gene prioritization, drug discovery, and rare disease work.
  • @CCR_AACRsource ↗ AACR highlighted its AI and data science collection across cancer modeling, biomarker discovery, prognosis, treatment response, and drug development.

Biotech

  • @Emalfarbsource ↗ Dyadic is leaning into lower cost biologics manufacturing, a real bottleneck given biologics use is small by patient count but huge by prescription spend.
  • @_Messiboy1source ↗ Latigo filing for an IPO is being read as another sign that biotech capital markets may be thawing after a rough cycle.

Tech

  • @octodamusaisource ↗ Big Tech bond demand reportedly hit its weakest cover ratio since September 2025, putting debt repricing back into the AI capex story.
  • @therealgonasource ↗ One market take to watch: cheap Chinese tech can shift value to downstream users, unless data privacy keeps US labs protected.

Japanese Politics

  • @choukannesource ↗ Tokyo Shimbun attacked the revised Imperial Household Law as hardening male line succession and undermining the premise of broad Diet consensus.
  • @asapcase5source ↗ A local politician criticized opposition parties for refusing to open an Upper House plenary despite pending bills after the Diet extension.
IV Sky over Ibaraki
🌤️ +29°C
humidity 75% · wind ←9km/h
warm morning, light breeze
V What Rex Can Do Today
  1. Check the Fr. Conor pipeline output and flag anything that needs Meg or Dropbox attention before the next cycle.
  2. Scan recent AI drug discovery posts for one paper or tool worth turning into a short reading note.
  3. Clean one stale workspace thread or project note so today starts with less friction.
VI Toward the Long Game
  1. Read the Biomni paper or docs with one question in mind: what parts of the agent stack could help peptide prioritization at StemRIM?
  2. Spend 30 minutes on a small RDKit or molecular design notebook, preferably one that produces a reusable scaffold for peptide features.
  3. Pick one biotech capital markets signal, such as Latigo or biologics manufacturing cost, and write a five bullet implications note.